Protective potentials of a potentized homeopathic drug, Lycopodium-30, in ameliorating azo dye induced hepatocarcinogenesis in mice

Molecular and Cellular Biochemistry

Volumn 285, Issue 1-2, 2006, Pages 121-131

  Pathak, Surajit ^a   Das, Jayanta Kumar ^a   Biswas, Surjyo Jyoti ^a   Khuda Bukhsh, Anisur Rahman ^a  

^a UNIVERSITY OF KALYANI   (India)

Author keywords

Hapatoprotection; Hepatocarcinogenesis; Lycopodium 30; p DAB; Toxicity biomarkers

Indexed keywords

4 DIMETHYLAMINOAZOBENZENE; ACID PHOSPHATASE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; AZO DYE; BIOLOGICAL MARKER; CARCINOGEN; GLUTATHIONE; HOMEOPATHIC AGENT; LIPID; LYCOPODIUM 30; LYCOPODIUM CLAVATUM EXTRACT; PHENOBARBITAL; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; CHEMICAL CARCINOGENESIS; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; DRUG MECHANISM; ENZYME ACTIVITY; LIPID PEROXIDATION; LIVER CANCER; LIVER CARCINOGENESIS; LIVER PROTECTION; MICRONUCLEUS; MITOSIS INDEX; MOUSE; NONHUMAN; SPERMATOZOON ABNORMALITY;

ANIMALS; CARCINOMA, HEPATOCELLULAR; LIPID PEROXIDATION; LIVER; LYCOPODIUM; MALE; MATERIA MEDICA; MICE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; P-DIMETHYLAMINOAZOBENZENE; PHENOBARBITAL; PLANT EXTRACTS; PROTECTIVE AGENTS; SPERM HEAD; SPERMATOZOA; SPLEEN; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA; LYCOPODIACEAE; LYCOPODIUM; LYCOPODIUM CLAVATUM;

EID: 33646191834     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-9065-7     Document Type: Article

References (32)

1. International Agency for Research on Cancer (IARC): On the evaluation of carcinogenic risk of chemicals to man, Group 2B, (Suppl 7): Pp. 440, 1987
2. Daoust R, Molnar F: Cellular populations and mitotic activity in rat liver parenchyma during azo dye carcinogenesis. Cancer Res 24: 1898-1909, 1964
3. Kitagawa T, Sugano H: Enhancement of azo-dye hepatocarcinogenesis with dietary phenobarbital in rats. Gann 68: 255-256, 1977
4. White AR, Ernst E: A trial method for assessing the adequacy of acupuncture treatments. Altern Ther Health Med 4(6): 66-71, 1998
5. Ernst E: The current position of complementary/alternative medicine in cancer. European J Cancer 39: 2273-2277, 2003
6. Sen P, Multani Asha S, Banerji P, Banerji P: Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: A novel treatment for human brain cancer. Int J Oncol 23: 975-982, 2003
7. Biswas SJ, Khuda-Bukhsh AR: Effect of a homeopathic drug, Chelidonium, in amelioration of p -DAB induced hepatocarcinogenesis in mice. BMC Complementary & Alternative Med 2/4: P. 1-16, 2002
8. Biswas SJ, Khuda-Bukhsh AR: Evaluation of protective potentials of a potentized hoemopathic drug, Chelidonium majus, during azo dye induced hepatocarcinogenesis in mice. Indian J Exp Biol 42: 698-714, 2004
9. Biswas SJ, Khuda-Bukhsh AR: Evaluation of protective potential of a crude plant extract (Chelidonium majus) against p -dimethylaminoazobenzene induced hepatocarcinogenesis in mice. 7th International Symposium on Predictive Oncology and Intervention Strategies, Nice, France, February 7-10, 2004
10. Biswas SJ, Pathak S, Bhattacharjee N, Khuda-Bukhsh AR: Efficacy of a potentized homeopathic drug, Carcinosin-200, fed alone and in combination with another drug, Chelidonium 200, in amelioration of p -DAB induced hepatocarcinogenesis in mice. J Altern Comp Med 11(5): 839-854, 2005
11. Biswas SJ, Bhattacharjee N, Khuda-Bukhsh AR: Efficacy of a plant extract (Chelidonium majus L) in combating induced hepatocarcinogenesis in mice. Food Chem Toxicol 2005 (in review)
12. Biswas SJ, Pathak S, Khuda-Bukhsh AR: Assessment of the genotoxic and cytrotoxic potential of an antiepileptic drug Phenobarbital, in mice: A time course study. Mutation Research 563: 1-11, 2004
13. Schmid W: Chemical Mutagens In: A.E. Hollaender (eds). Principles and Methods of Detection. Plenum Press, New York, 1976
14. Wyrobek AJ, Watchmaker G, Gordon L: Handbook of mutagenecity testing protocols In: B.J. Kilbey, M. Legator, W. Nichols and C. Ramel (eds). Elsevier Science, Netherland, 1984, pp 733-750
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with Folin-Phenol reagent. J Biol Chem 193: 265-275, 1951
16. Buege JA, Aust SD: Microsomal lipid peroxidation. Methods Enzymol 105: 302-310, 1984
17. Walter K, Schutt C: Acid and alkaline phosphatase in serum (Two point method). In: H.U. Bergmeyer (ed). Methods in Enzymatic Analysis, Vol 2, Academic Press, New York, USA. 1974a, pp. 856-860
18. Bergmeyer HU, Brent E: Methods of Enzymatic analysis, In: H.U. Bergmeyer (ed). Verlag Chemie Weinhein, Vol 2, Academic Press, New York, 1974 pp 735-760
19. EIIman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70-77, 1959
20. Dave BJ, Hsu TC, Hong WK, Pathak S: Non random distribution of mutagen induced chromosome breaks in lymphocytes of patients with different malignancies, Int. J. Oncol. 5: 733-740, 1994
21. Hashimoto Y, Degawa M, Watanabe HK, Tada M: Amino acid conjugation of N-hydroxy-4- aminoazobenzene dyes: A possible activation process of carcinogenic 4-aminoazobenzenic metabolites. Gann 72: 937-943, 1981
22. Williams GM, Weisburger JH: Chemical Carcinogenesis. In: M.O. Amdur, J. Doull and C.D. Klaassen (eds). The basic Science of Poisons, Casarett and Doulls Toxicology, Mcgraw-Hill Inc, New York, 1991, pp 127-200
23. Ohnishi S, Murata M, Degawa M, Kawanishi S: Oxidative DNA damage induced by an N-hydroxy metabolite of carcinogenic 4-dimethylaminoazobenzene. Jpn J Cancer Res 92(1): 23-29, 2001
24. Karasaki S: Cell proliferation and subcellular localization of alkaline phosphatase activity in rat liver parenchyma during azo dye carcinogenesis. Cancer Res 35: 482-491, 1975
25. Plaa GL, Amdun AM, Doull J, Klasser CD: Toxic responses of the liver. 4th Ed. Pergamon Press, 1991
26. Timbrell JA: Principles of biochemical toxicology. London, Taylor and Francis, 1991
27. Vinitha R, Thangaraju M, Sachdanandam P: Effect of administering cyclophosphamide and vitamin E on the levels of tumor-marker enzymes in rats with experimentally induced fibrosarcoma. Japanese J Med Sci Biol 48: 145-156, 1995
28. Bain PJ, Latimer KS, Mahaffey EA, Prasse KW: Duncan and Prasse's Veterinary Medicine, Liver Clinical Pathology, 4th Ed, Ames Iowa State Press, 2003, pp 193-214
29. Valentine BA, Blue JT, Shelley SM, Cooper BJ: Increased serum alanine aminotransferase activity associated with muscle necrosis in the dog. J. Vet. Intern. Med 4: 140-143, 1990
30. Stockham SL, Scott MA: Fundamentals of Veterinary Clinical Pathology. Ames, Iowa State University Press, 2002, pp 434-459
31. Khuda-Bukhsh AR: Potentized homeopathic drugs act through regulation of gene expression: A hypothesis to explain their mechanism and pathways of action in vivo. Com Ther Med 5: 43-46, 1997.
32. Khuda-Bukhsh AR: Towards understanding molecular mechanisms of action of homeopathic drugs: An overview. Mol Cell Biochem 253: 339-345, 2003